CPHI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Breakfast Session: Manufacturing Excellence
Driving excellence in pharmaceutical manufacturing

Please note there is a USD 5 charge to attend this session

Make sure you include this session as an 'add-on' if you're registering for the first time, or you can 'upgrade' an existing registration here.

Dr Kishore Hotha
Global Vice President, AR&D Operations


Location: Room 201A | Date: May 8th 2024

08:30-09:45 (EST)
Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence.

Antibody-drug conjugates (ADCs) are pioneering biologics that merge antibodies’ specificity with small molecules’ potency. With a handful of FDA-approved ADCs in the market and many under development, ADCs are poised to revolutionize therapeutics. This talk examines the complexities of ADC production, emphasizing the importance of process characterization and the pivotal role of supply chain characteristics, safety requirements, and Contract Manufacturing Organizations (CMOs) with proficiency. The swift transition of antibody-drug conjugate (ADC) programs from early to advanced clinical stages underscores the urgency for quick and efficient commercial launch preparation. We will delve into strategies to hasten commercial readiness, supply chain strategy, the significance of partnering with adept contract development and manufacturing organizations (CDMOs), and the challenges of ADC production.


  • Dr Kishore Hotha, Veranova, Global Vice President, AR&D Operations
Full agenda
Full conference agendas
Our community
Moments from last year
img missing
img missing
Pharma professional showing individual work on a laptop at CPHI North America
Join us at CPHI North America